Search
Monopar Therapeutics Inc
MNPRAdd to Watchlist
97.790USD
+2.760+2.90%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
655.10MMarket Cap
LossP/E TTM
Monopar Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.85
54.99%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its current assets were 140.46M, with a year-on-year change of 132.97.
What are the total assets of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its total assets of Monopar Therapeutics Inc were 140.72M, with a year-on-year change of 133.40.
What are the total liabilities of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its total liabilities of Monopar Therapeutics Inc were 2.89M, with a year-on-year change of -44.99.
What is the total equity of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its total equity of Monopar Therapeutics Inc was 137.83M, with a year-on-year change of 150.43.
What is the net investment of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its net investment of Monopar Therapeutics Inc was -63.45M, with a year-on-year change of -342.54.
What is the net financing of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its net financing of Monopar Therapeutics Inc was 91.57M, with a year-on-year change of 54.45.
What is the Earnings Per Share (EPS) of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.85, with a year-on-year change of 54.99.
What is the Return on Equity (ROE) of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -14.22, with a year-on-year change of 72.34.
What is the Return on Assets (ROA) of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -13.65, with a year-on-year change of 70.39.
What is the operating profit of Monopar Therapeutics Inc?
According to Monopar Therapeutics Inc's FY2025 earnings report, its operating profit was -16.70M, with a year-on-year change of -3.36.